Insulin degludec and liraglutide Subcutaneous and Ocrelizumab Intravenous
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Ocrevus
- Insulin degludec and liraglutide Subcutaneous-Octagam
- Insulin degludec and liraglutide Subcutaneous-Octagam Gammagard S/D
- Insulin degludec and liraglutide Subcutaneous-Octocaine
- Insulin degludec and liraglutide Subcutaneous-Octocaine 100
- Insulin degludec and liraglutide Subcutaneous-OctreoScan
- Ocrelizumab Intravenous-Insulin degludec Subcutaneous
- Ocrelizumab Intravenous-Insulin detemir
- Ocrelizumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Ocrelizumab Intravenous-Insulin Detemir (Vials)
- Ocrelizumab Intravenous-Insulin detemir Subcutaneous
- Ocrelizumab Intravenous-Insulin glargine